Literature DB >> 25249502

Determination of major UDP-glucuronosyltransferase enzymes and their genotypes responsible for 20-HETE glucuronidation.

Yazun Bashir Jarrar1, Eun-Young Cha1, Kyung-Ah Seo1, Jong-Lyul Ghim2, Hyo-Ji Kim1, Dong-Hyun Kim1, Su-Jun Lee1, Jae-Gook Shin2.   

Abstract

The compound 20-HETE is involved in numerous physiological functions, including blood pressure and platelet aggregation. Glucuronidation of 20-HETE by UDP-glucuronosyltransferases (UGTs) is thought to be a primary pathway of 20-HETE elimination in humans. The present study identified major UGT enzymes responsible for 20-HETE glucuronidation and investigated their genetic influence on the glucuronidation reaction using human livers (n = 44). Twelve recombinant UGTs were screened to identify major contributors to 20-HETE glucuronidation. Based on these results, UGT2B7, UGT1A9, and UGT1A3 exhibited as major contributors to 20-HETE glucuronidation. The Km values of 20-HETE glucuronidation by UGT1A3, UGT1A9, and UGT2B7 were 78.4, 22.2, and 14.8 μM, respectively, while Vmax values were 1.33, 1.78, and 1.62 nmol/min/mg protein, respectively. Protein expression levels and genetic variants of UGT1A3, UGT1A9, and UGT2B7 were analyzed in human livers using Western blotting and genotyping, respectively. Glucuronidation of 20-HETE was significantly correlated with the protein levels of UGT2B7 (r(2) = 0.33, P < 0.001) and UGT1A9 (r(2) = 0.31, P < 0.001), but not UGT1A3 (r(2) = 0.02, P > 0.05). A correlation between genotype and 20-HETE glucuronidation revealed that UGT2B7 802C>T, UGT1A9 -118T9>T10, and UGT1A9 1399T>C significantly altered 20-HETE glucuronide formation (P < 0.05-0.001). Increased levels of 20-HETE comprise a risk factor for cardiovascular diseases, and the present data may increase our understanding of 20-HETE metabolism and cardiovascular complications.
Copyright © 2014 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  20-hydroxyeicosatetraenoic acid; arachidonic acid; genetic polymorphisms; uridine diphosphate-glucuronosyltransferase

Mesh:

Substances:

Year:  2014        PMID: 25249502      PMCID: PMC4617135          DOI: 10.1194/jlr.M051169

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  37 in total

Review 1.  Human UDP-glucuronosyltransferases: metabolism, expression, and disease.

Authors:  R H Tukey; C P Strassburg
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

Review 2.  The role of 20-HETE in androgen-mediated hypertension.

Authors:  Cheng-Chia Wu; Michal Laniado Schwartzman
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-06-22       Impact factor: 3.072

3.  Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac.

Authors:  C King; W Tang; J Ngui; T Tephly; M Braun
Journal:  Toxicol Sci       Date:  2001-05       Impact factor: 4.849

4.  Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids.

Authors:  Anne Konkel; Wolf-Hagen Schunck
Journal:  Biochim Biophys Acta       Date:  2010-09-30

5.  Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events.

Authors:  Jun-Yan Liu; Ning Li; Jun Yang; Nan Li; Hong Qiu; Ding Ai; Nipavan Chiamvimonvat; Yi Zhu; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

6.  Determination of free and glucuronide conjugated 20-hydroxyarachidonic acid (20-HETE) in urine by gas chromatography/negative ion chemical ionization mass spectrometry.

Authors:  B Watzer; S Reinalter; H W Seyberth; H Schweer
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2000-03       Impact factor: 4.006

Review 7.  20-hydroxyeicosatetraenoic acid, endothelial dysfunction and hypertension.

Authors:  Mary Pat Kunert; Ines Drenjancević
Journal:  Med Glas (Zenica)       Date:  2011-08

Review 8.  20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension.

Authors:  Jan M Williams; Sydney Murphy; Marilyn Burke; Richard J Roman
Journal:  J Cardiovasc Pharmacol       Date:  2010-10       Impact factor: 3.105

9.  Testosterone-dependent increase in blood pressure is mediated by elevated Cyp4A expression in fructose-fed rats.

Authors:  Harish Vasudevan; Violet G Yuen; John H McNeill
Journal:  Mol Cell Biochem       Date:  2011-09-06       Impact factor: 3.396

10.  Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.

Authors:  Sumit Parmar; Julia Carolin Stingl; Ariana Huber-Wechselberger; Alexander Kainz; Wilfried Renner; Uwe Langsenlehner; Peter Krippl; Jürgen Brockmöller; Elisabeth Haschke-Becher
Journal:  Breast Cancer Res       Date:  2011-06-09       Impact factor: 6.466

View more
  7 in total

Review 1.  Conflicting roles of 20-HETE in hypertension and renal end organ damage.

Authors:  Chao Zhang; George W Booz; Qing Yu; Xiaochen He; Shaoxun Wang; Fan Fan
Journal:  Eur J Pharmacol       Date:  2018-06-07       Impact factor: 4.432

Review 2.  Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.

Authors:  Fan Fan; Richard J Roman
Journal:  J Am Soc Nephrol       Date:  2017-07-12       Impact factor: 10.121

Review 3.  Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.

Authors:  Fan Fan; Ying Ge; Wenshan Lv; Matthew R Elliott; Yoshikazu Muroya; Takashi Hirata; George W Booz; Richard J Roman
Journal:  Front Biosci (Landmark Ed)       Date:  2016-06-01

Review 4.  Cytochrome P450 eicosanoids in hypertension and renal disease.

Authors:  Fan Fan; Yoshikazu Muroya; Richard J Roman
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-01       Impact factor: 2.894

5.  A Gilbert syndrome-associated haplotype protects against fatty liver disease in humanized transgenic mice.

Authors:  Steffen Landerer; Sandra Kalthoff; Stefan Paulusch; Christian P Strassburg
Journal:  Sci Rep       Date:  2020-05-26       Impact factor: 4.379

Review 6.  Drug-drug-gene interactions as mediators of adverse drug reactions to diclofenac and statins: a case report and literature review.

Authors:  Nada Božina; Lana Ganoci; Livija Simičević; Katarina Gvozdanović; Iva Klarica Domjanović; Margareta Fistrek Prlić; Tena Križ; Ana Borić Bilušić; Mario Laganović; Tamara Božina
Journal:  Arh Hig Rada Toksikol       Date:  2021-06-28       Impact factor: 2.078

7.  Alterations in the gene expression of drug and arachidonic acid-metabolizing Cyp450 in the livers of controlled and uncontrolled insulin-dependent diabetic mice.

Authors:  Yazun Bashir Jarrar; Luay Al-Essa; Abdulhasib Kilani; Mariam Hasan; Walid Al-Qerem
Journal:  Diabetes Metab Syndr Obes       Date:  2018-09-25       Impact factor: 3.168

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.